Rankings
▼
Calendar
NXTC Q4 2021 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$36M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$17M
Net Income
-$17M
EPS (Diluted)
$-7.35
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$14M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$242M
Total Liabilities
$9M
Stockholders' Equity
$233M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$17M
-$16M
-5.1%
Net Income
-$17M
-$15M
-9.6%
← FY 2021
All Quarters
Q1 2022 →